Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

Tekmira Pharmaceuticals Corporation

Tekmira is a leader in the development of the therapeutic agents based upon Nobel prize-winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira’s three lead RNAi product candidates target cholesterol management, cancer and Ebola infection.

Investment year: 2002
Industry sector: Biotechnology
Region: Prairies and West
Website
Follow Tekmira Pharmaceuticals Corporation